YS Biopharma Co., Ltd. YS
1.02 +1.02
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Mar 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|
| 687.20M | 502.95M | 257.02M | |
| 533.84M | 385.88M | 197.36M | |
| -139.38M | -118.96M | -125.85M | |
| -283.47M | -236.67M | -208.44M | |
| -1.56 | -1.71 | -3.10 |
Balance sheet
| Fiscal year | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|
| 370.37M | 271.07M | 390.46M | |
| 1.72B | 1.44B | 1.17B | |
| 991.30M | 770.50M | 390.58M | |
| 498.63M | 380.59M | 18.44M | |
| 728.45M | -698.97M | -508.86M |
Cash flow
| Fiscal year | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|
| -182.47M | -173.55M | -246.61M | |
| -56.98M | -298.92M | -104.24M | |
| 317.45M | 364.56M | 739.26M | |
| -52.69M | -295.31M | -104.24M | |
| 99.30M | -119.39M | 388.41M |